Multimodal Computed Tomography in Patients With Acute Hemorrhagic Stroke

Recruiting Observational Study
Acute Hemorrhagic Stroke
No Placebo Group Every participant receives an active treatment — no one gets a placebo. Healthy Volunteers Welcome You do not need to have the condition being studied to take part. No Study Drug Researchers observe your health over time — no experimental treatment is given.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
18 – 85
Sex
Any
Study type
Observational
Participants needed
10,000 (estimated)
Sponsor
Xiaolin Chen, MD · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial
Acute hemorrhagic stroke is a series of neurosurgical diseases characterized by bleeding with high morbidity and mortality. It accounts for about 20% of all strokes worldwide and mainly includes subtypes such as intracerebral hemorrhage (ICH) and subarachnoid hemorrhage (SAH). Multimodal computed tomography including non-contrast computed tomography, computed tomography angiography and computed to…
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: 1. age ≥ 18, ≤ 85 years; 2. presence with hemorrhagic stroke Exclusion Criteria: 1. with a history of previous history of ischemic/hemorrhagic stroke; 2. admission to the emergency department more than a week after symptom onset; 3. serious medical history or existing comorbid…
Contacts

Xiaolin Chen, M.D.

13810624845

chenxiaolin@bjtth.org

CONTACT